Meet ContraFect — the Biotech Company Reports Developing Infectious Disease Treatments for When Antibiotics Fail
Photo by freestocks on Unsplash
Dr. Roger Pomerantz, Chairman and CEO of ContraFect Corp. (NASDAQ: CFRX), was a guest speaker at Benzinga’s Global Small Cap Conference in December 2021.
